Received: from AM7PR02MB6257.eurprd02.prod.outlook.com (2603:10a6:20b:1b6::12) by DB9PR02MB7817.eurprd02.prod.outlook.com with HTTPS; Thu, 2 Jul 2026 09:22:15 +0000 Received: from GVXPR02MB12202.eurprd02.prod.outlook.com (2603:10a6:150:318::18) by AM7PR02MB6257.eurprd02.prod.outlook.com (2603:10a6:20b:1b6::12) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.181.10; Thu, 2 Jul 2026 09:22:14 +0000 Received: from GVXPR02MB12202.eurprd02.prod.outlook.com ([fe80::7e68:6b0b:67d4:d05f]) by GVXPR02MB12202.eurprd02.prod.outlook.com ([fe80::7e68:6b0b:67d4:d05f%2]) with mapi id 15.21.0159.018; Thu, 2 Jul 2026 09:22:14 +0000 From: "Andrus Varki - RA" To: "Info - SOM" Cc: =?utf-8?Q?K=C3=A4rolin_Jenas_-_RA?= References: <0b1142f2de5b4ee9b77a206ee9671966@ravimiamet.ee> In-Reply-To: Subject: =?utf-8?Q?Ed:_Eeln=C3=B5u_edastamine_koosk=C3=B5last?= =?utf-8?Q?amiseks_ja_arvamuse_avaldamiseks?= Date: Thu, 2 Jul 2026 12:22:14 +0300 Keywords: Mall Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0066_01DD0A1D.F4746120" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQIOkpl4/ke9+WNmGnvinYgaN9pG2wEidV1AAvAO1mEBgZBMcAI+CNbTAO+NVD0CDMzEsQJQEHqMAmmhbPs= Authentication-Results: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; X-MS-Exchange-Organization-ExpirationStartTime: 02 Jul 2026 09:22:14.4932 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: c1307a6c-4aac-4031-d939-08ded81b674c X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: GVXPR02MB12202:EE_|AM7PR02MB6257:EE_|DB9PR02MB7817:EE_ X-MS-Exchange-Organization-AuthSource: GVXPR02MB12202.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Office365-Filtering-Correlation-Id: c1307a6c-4aac-4031-d939-08ded81b674c X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|23010399003|31052699007|366016|39142699007|13003099007|4143699003|11063799006|56012099006|18002099003|8096899003|22082099003|55112099003|41050700001; X-Forefront-Antispam-Report: CIP:255.255.255.255;CTRY:;LANG:ja;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GVXPR02MB12202.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(23010399003)(31052699007)(366016)(39142699007)(13003099007)(4143699003)(11063799006)(56012099006)(18002099003)(8096899003)(22082099003)(55112099003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 02 Jul 2026 09:22:14.1915 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: c1307a6c-4aac-4031-d939-08ded81b674c X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: GVXPR02MB12202.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: Hosted X-MS-Exchange-Transport-CrossTenantHeadersStamped: AM7PR02MB6257 X-MS-Exchange-Transport-EndToEndLatency: 00:00:01.6557090 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0181.008 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: 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 Content-Language: et x-ms-exchange-organization-originalclientipaddress: 45.156.32.33 x-ms-exchange-organization-originalserveripaddress: 2603:10a6:150:318::18 X-OlkEid: 00000000D07AAE8E23CDBE4CA04D01CCD82FCB7E070034AD76187591974DBF6C4F76951C873A01000200000000005797C783AAECB34FA6C879FF487E64D9000000000DCB0000EE0EAEC8FA76264F9A6D37A057E55F88 X-MS-Has-Attach: X-MS-TNEF-Correlator: x-codetwoprocessed: true x-codetwo-clientsignature-inserted: true X-MS-Exchange-Organization-AuthMechanism: 04 X-MS-Exchange-CrossTenant-MailboxType: HOSTED X-MS-Exchange-CrossTenant-UserPrincipalName: QoHIAczEIAUNtBwm3Aw/W4+CbN6W8Hnfsl7fZxSWCSjX7kotVFgdDGNrzWATJnS0tDdXHPSAmpKnm0gUGJOYyUKNKypV7DiwUkMVpl02GQY= acceptlanguage: et-EE, en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-07-02T09:22:13.704Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; This is a multipart message in MIME format. ------=_NextPart_000_0066_01DD0A1D.F4746120 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Teie:    09.06.2026 nr 1.2-3/1490-1 Meie:   02.07.2026 nr JUR-3/3264-2 Tere Ravimiametil ei ole tähelepanekuid eelnõule. Lugupidamisega Andrus Varki juhataja Õigusosakond Ravimiamet 737 4140 www.ravimiamet.ee Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. ------=_NextPart_000_0066_01DD0A1D.F4746120 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable
Teie:=E2=80=82=E2=80=82=E2=80=82=E2=80=8209.06.2026 nr = 1.2-3/1490-1
Meie:=E2=80=82=E2=80=82=E2=80=8202.07.2026 nr JUR-3/3264-2


Tere

Ravimiametil ei ole t=C3=A4helepanekuid eeln=C3=B5ule.



Lugupidamisega

Andrus Varki

juhataja

=C3=95igusosakond


Ravimiamet

737 4140

www.ravimiamet.ee


Selles = e-kirjas sisalduv teave (kaasa arvatud manused) on m=C3=B5eldud = ametialaseks kasutamiseks ning seda v=C3=B5ivad kasutada vaid e-kirja = adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt = v=C3=A4ljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. = Juhul, kui Te olete saanud k=C3=A4esoleva e-kirja eksituse t=C3=B5ttu, = teavitage sellest koheselt saatjat ning kustutage e-kiri. 
This e-mail and any attachments transmitted may = contain confidential and privileged information. If you are not the = intended recipient, please notify the sender immediately by = returning the e-mail and permanently deleting what you have = received. Any dissemination or use of this information by a third person without permission is = prohibited and may be illegal. 



 

------=_NextPart_000_0066_01DD0A1D.F4746120--